TY  - JOUR
AU  - Gonzalez-Lopez, Esther
AU  - Escobar-Lopez, Luis
AU  - Obici, Laura
AU  - Saturi, Giulia
AU  - Bezard, Mélanie
AU  - Saith, Sunil E
AU  - AbouEzzeddine, Omar F
AU  - Mussinelli, Roberta
AU  - Gagliardi, Christian
AU  - Kharoubi, Mounira
AU  - Griffin, Jan M
AU  - Dispenzieri, Angela
AU  - Vilches, Silvia
AU  - Perlini, Stefano
AU  - Longhi, Simone
AU  - Oghina, Silvia
AU  - Rivas, Adrian
AU  - Grogan, Martha
AU  - Maurer, Mathew S
AU  - Damy, Thibaud
AU  - Palladini, Giovanni
AU  - Rapezzi, Claudio
AU  - Garcia-Pavia, Pablo
PY  - 2022
DO  - 10.1016/j.jaccao.2022.07.007
UR  - http://hdl.handle.net/20.500.12105/16472
AB  - BACKGROUNDTransthyretin amyloid cardiomyopathy (ATTR-CM) is increasingly recognized as a treatable cause of heart failure (HF). Advances in diagnosis and therapy have increased the number of patients diagnosed at early stages, but prognostic data on...
LA  - eng
PB  - Elsevier
TI  - Prognosis of Transthyretin Cardiac Amyloidosis Without Heart Failure Symptoms.
TY  - journal article
ER  -